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A procedure for simultaneous identiﬁcation and quantiﬁcation of canrenone and its biotransformed product 11-α-hydroxy-
canrenone by high-performance liquid chromatography with ultraviolet detector (HPLC-UVD) and mass spectrometry (LC-MS)
methodswasproposed.TheoptimaldeterminationvariablesontheHPLC-UVDorLC-MScoupledwithaZORBAXEclipseXDB-
C18 column (150mm × 4.6mm, 5μm) were set as follows: detection wavelength of 280nm, mobile phase of water and methanol
gradient elution, temperature for the chromatographic column of 30◦C, ﬂow rate of mobile phase of 0.8mL/min, sample injection
volume of 5μL, and elution time of 40min. The MS conditions were set as follows: the ﬂow rate of sheath gas, aux gas, and sweep
gas were kept at 35 arb, 5 arb, and 0 arb, respectively. The temperature of capillary was held at 300◦C, and capillary voltage was
set at 30.00V. Tube lens were performed at 100.00V. The proposed method was validated by linearity (r2 ≥ 0.9910), average
recovery (94.93%, RSD1.21%), precision (RSD ≤ 1.31%), limit of detection, and limit of quantiﬁcation (LOD 0.1∼0.12mg/L,
LOQ 0.5∼0.67mg/L), which proved to be aﬀordable for simultaneously determining canrenone and its bio-transformed product
11-α-hydroxy-canrenone.
1.Introduction
Canrenone (CR), a cardiovascular drug, a sort of steroid, is
spironolactone’s major metabolite and has been widely used
as a nonselective aldosterone receptor antagonist clinically to
treat heart failure, high blood pressure, edema, liver ascites,
and other cardiovascular diseases [1, 2]. However, canrenone
also has the signiﬁcant side eﬀects including ataxia, mental
confusion, and hirsutism. To enhance curative eﬀect and
reduce those side eﬀects, hydroxylation and/or nitration
steps were developed to synthesize its derivatives [3, 4].
Eplerenone is the ﬁrst agent in a new class of drugs known as
the selective aldosterone-receptor antagonists (SARAs), and
has a 15- to 20-fold lower aﬃnity for the mineralocorticoid
receptor; however, fewer adverse events occur due to its spe-
ciﬁc binding to aldosterone [5–8]. Eplerenone can be semi-
chemically synthesized from canrenone, which involves the
11-α-hydroxylation as the ﬁrst step and one of the most key
steps [9, 10]. The production of 11-α-hydroxy-canrenone by
the 11-α-hydroxylation reaction can be conducted by chemi-
cal synthesis or microbial transformation (Figure 1). Chemi-
calsynthesiswillleadtosomeproblemsincludinglowstereo-
and region-selectivity, strict reaction condition environmen-
tal pollution, and complicated and expensive production
processes, while microbial transformation process can be
considered as a “green” producing alternative that overcomes
the above problems from chemical synthesis [11–14].
The hydroxylation of steroids by fungal biocatalysts has
been known for many years, this procedure remains one of
the most useful preparative methods for the introduction
of hydroxyl groups at sites of the steroid nucleus remote
from other functionality, and the value of microbial steroid2 Journal of Biomedicine and Biotechnology
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Figure 1: 11-α-hydroxylation of canrenone by microbial transformation.
hydroxylation in the preparation of pharmacologically active
steroids is well established. In our primary experiments,
afungusofRhizopusspUJS-0602wasscreenedforproducing
the 11-α-hydroxy-canrenone from canrenone. However, a
keystepofproposingareliableassaymethodfordetermining
canrenone and 11-α-hydroxy-canrenone was necessary to
evaluate productivity of 11-α-hydroxy-canrenone, consum-
ingrateofcanrenone,andbiotransformatingyield.However,
fewreferenceswereprovidedforsimultaneouslydetermining
11-α-hydroxy-canrenone and canrenone in biotransforma-
tion by high-performance liquid chromatography (HPLC),
but few related works dealing with the simultaneous quan-
titation of spironolactone and canrenone in human [15–
18]a n dr a t[ 19] plasma samples, in urine samples [20, 21],
or in tablets [22]. Similar structure between 11-α-hydroxy-
canrenone and canrenone also increases the diﬃculties for
accurate determination of the two substances by the other
methods such as colorimetry or thin-layer chromatography
(TLC).
The aim of the present study was to propose a simple,
quick, accurate, and feasible determining procedure for
simultaneous identiﬁcation and quantiﬁcation of canrenone
and 11-α-hydroxy-canrenone by two novel reversed-phase
LC-MS and HPLC-UV.
2. ExperimentalChemicals and Reagents
Standard canrenone and 11-α-hydroxy-canrenone were pur-
chased from the Fisher Scientiﬁc International Inc. (Hamp-
ton, New Hampshire, USA). For microbial transformation,
substrate canrenone with purity ≥97% was purchased from
TaiYuan RHF Co. (Shanxi, China). Methanol (Tedia, Baker,
USA) was of HPLC grade and all other chemicals were of
analytical reagent grade.
3. Microbial Transformation Procedure
Microorganism Rhizopus sp UJS-0602 was activated on the
PDAslantsfor5dat28◦C,thenwashedoutwithsterilewater
and transferred to fresh liquid medium a 500mL erlenmeyer
ﬂask with 100mL liquid culture medium, and cultured for
3 3ha t2 8 ◦C with the shaking rate of 160r/min. Further, the
substratecanrenonedissolvedindimethylformamide(DMF;
3.6g/l) was added into the cultured broth and transformed
for another 48 hours at the same culture conditions.
3.1. Sample Preparation. Mixed standard stock solution of
canrenone and 11-α-hydroxy-canrenone (10g/L) was pre-
pared by accurately weighing 10mg of canrenone and 11-
α-hydroxy-canrenone standards, dissolving into 1mL of
HPLC-grademethanol.Theworkingstandardsolutionswere
prepared by diluting the mixed standard solution with
methanol to a series of proper concentrations (3g/L, 1.5g/L,
0.75g/L, 0.3g/L, and 0.1g/L). The standard stock solution
and working solutions were all stored at 4◦C.
The microbial transformed broth was ﬁltered into two
fractions of mycelia and ﬁltrate which were further extracted
with ethyl acetate in an amount ﬁve-times its volume for
three times, respectively. The microbial transformed sample
was obtained by collecting and concentrating the organic
phases to dry, redissolving, and diluting with methanol to
volume of 100mL for HPLC analysis.
3.2. LC-MS and HPLC-UV Analysis. The LC-MS qualitative
analysis was carried out on an ion trap Thermo LXQ Finni-
ganSURYEYOR(USA).Theseparationwasperformedusing
a ZORBAX Eclipse XDB-C18 column (150mm × 4.6mm,
5μm)suppliedbyAgilentTechnologies,USA.Thequalitative
gradient elution system consisted of methanol (Mobile Phase
A)a n dw a t e r( Mobile Phase B). The separation was achieved
using the following gradient program: 0–40min (10%∼50%
Mobile Phase A), 40–60min (50%∼100% Mobile Phase
A). The ﬂowrate was set at 0.8mL/min and the samples
were injected automatically (5.0μL of each other). The
column was thermostatically controlled at 30◦C and the
chromatogram was monitored at 280nm. The ﬂow rate of
sheath gas, aux gas, and sweep gas were kept at 35arb, 5arb,
and 0arb, respectively. The temperature of capillary was held
at 300◦C and capillary voltage was set at 30.00V. Tube lens
were performed at 100.00V.
The HPLC-UV analysis was carried out on a Waters
Alliance LC-20AT (SHIMADZU, Japan) liquid chromato-
graph connected to a model 2996 (DAD) diode array detec-
tor and controlled by LC Driver Ver.2.0 for Waters Empower
software. The optimized gradients employed were 0–40min,
10%∼100% methanol, and 90%∼0% water. The column
and other chromatographic conditions were the same asJournal of Biomedicine and Biotechnology 3
thoseusedfortheLC-MSanalysis.Datawereprocessedusing
Waters Empower software.
3.3. Calibration Curves. The working standard solutions
were brought to room temperature and an aliquot of 5.0μL
was injected into HPLC for construction of calibration
curves. The column and chromatographic condition were
the same as described in Section 3.3 of HPLC-UV. The ﬁve
concentrations of working standard solutions were analyzed
in triplicate and calculating the calibration curves were cal-
culated by linear regression of the double logarithmic plots
of the peak area versus the concentration of the working
standard solution injected.
The linearity was determined by the correlation coef-
ﬁcients of the analytical curves generated by injections of
the working solutions at ﬁve concentration levels. In the
method for quantiﬁcation of canrenone and 11-α-hydroxy-
canrenone in microbial transformation ﬂuid, the analytical
curves were constructed in triplicate by diluting the mixed
standard solutions with methanol, which resulted in the ﬁnal
concentrations of 3g/L, 1.5g/L, 0.75g/L, 0.3g/L, and 0.1g/L.
3.4. Accuracy. Standard addition method was performed to
evaluate the accuracy of the HPLC method. The procedure
was summarized as follows: to determine 1mL sample solu-
tion with the same concentration prepared in Section 3.1
for 5 parts accurately, and 1mL of 10% canrenone standard
solution was added to each sample solution. The prepared
5 samples above were analyzed in turn by HPLC-UV. The
average recoveries were calculated by the following formula:
Recovery (%) =
Canrenone amount found

g

−Original Canrenone amount in sample solution

g

Canrenone added amount

g
 ×100%, (1)
with relative standard deviations (RSD%) = (SD/mean) ×
100%.
3.5. Repeatability. For repeatability test, ﬁve independent
analytical sample solutions from the same batch of sample
were prepared in same procedures noted in Section 3.1,
RSD% values of the obtained contents of each analyte were
used to estimate repeatability.
3.6. Precision and Intermediate Precision. The stability test
was chosen to determine the precision of the HPLC-UV
method. The same sample solution prepared in Section 3.1
was analyzed as described in Section 3.3 of HPLC-UV in 6
diﬀerent hours: 0h, 4h, 8h, 12h, 18h, and 24h throughout
a day. Variations of the peak area were taken as the measures
of precision and expressed as RSD%. Intermediate precision
was determined by analyzing the mixed standard solution
with the same concentration employed in Section 3.1 con-
tinuously for 5 times. Precision was expressed in terms of
RSD%.
3.7. Limit of Detection (LOD) and Limit of Quantitation
(LOQ). LOD and LOQ were estimated experimentally by
injectingstandardsolutionsofcanrenoneand11-α-hydroxy-
canrenone diluted in methanol under the above chromato-
graphic conditions in Section 3.2 of HPLC-UV until the
signal-to-noise ratio forthestandardsreached a 3:1ratio for
LOD and 10:1 for LOQ.
4. Results andDiscussion
4.1.IdentiﬁcationofCanrenoneand11-α-Hydroxy-Canrenone
by LC-MS. For the purpose of correct identiﬁcation, an LC-
MS analysis was performed on standard under the LC-MS
conditions. The previous chromatographic conditions for
determination of the two sterols in microbial transformation
ﬂuid by LC-MS were used as the basis for mobile phase
selection and optimization. Unfortunately, the reported
gradient elution of methanol-water could not be applied to
the separation of canrenone and 11-α-hydroxy-canrenone.
Under this circumstance, the gradient elution program was
carefully adjusted and after several trials the new gradient
program was selected until it permitted the best separation
ability for the two sterols. Figure 2 shows that under the
optimized LC-MS conditions, canrenone and 11-α-hydroxy-
canrenone were separated and identiﬁed by analysing their
mass spectra. The results of MS spectrogram are shown in
Figure 2. Comparing the standards of 11-α-hydroxylation
of canrenone Figure 2(A) and canrenone Figure 2(B), the
mass-to-charge ratios of each molecular ion peak (M +
H) were 357.4 and 341.4, respectively. According to the
references, the molecular weight of 11-α-hydroxylation of
canrenone and canrenone are 356.4 and 340.4, which meant
that the molecular weight of 11-α-hydroxylation is 16 more
than canrenone. Hence, the hydroxylation of canrenone has
occurred by the selected biotransforming strain Rhizopus sp
UJS-0602.
4.2. Quantitative Analysis of Canrenone and 11-α-Hydroxy-
Canrenone by HPLC-UV. The proposed LC-MS method
was successfully applied to simultaneous determination of
canrenone and 11-α-hydroxy-canrenone in microbial trans-
formation ﬂuid. But it cost a lot of time under the LC-MS
conditions described in Section 3.3. The optimal condition
for the extraction by HPLC-UV of canrenone and 11-α-
hydroxy-canrenone was selected and presented in details in
Section 3.3.
As shown in Figure 3, canrenone and 11-α-hydroxy-can-
renone were comprehensively separated and their retention
times were at 29min and 33min severally. From the picture,
we can see that the peak of canrenone at 33min reduced
radically after transformation reaction when the peak of
11-α-hydroxy-canrenone at 29min raised sharply, which4 Journal of Biomedicine and Biotechnology
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Figure 2: LC-MS chromatograms of mixed standards (a) and (b) in negative-ion mode. HPLC was performed on a ZORBAX Eclipse XDB-
C18 column (150mm × 4.6mm, 5μm) at the column temperature of 30◦C. The separation was achieved using the following gradient
program: 0–40min (10%∼50% methanol), 40–60min (50%∼100% methanol). The ﬂowrate was at 0.8mL/min and the sample injection
volume was 5.0μL. Peak assignments: (a) canrenone; (b) 11-α-hydroxy-canrenone. MS spectrograms (A) and (B) stand for the molecular
weight of the peak (a) and (b) at 357.44 and 341.40amu, respectively.
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Figure 4: Representative chromatograms of substrate canrenone before transformation (α), and of bioconversion broth obtained after
conversion for 48h (β), and of blank (γ) peaks: a = canrenone, b = 11-α-hydroxy-canrenone.
Table 1: Parameters of the analytical curves, LOD, and LOQ for canrenone and 11-α-hydroxy-canrenone quantiﬁcation by HPLC-UV.
Standard Concentration
range (g/L) Calibration curvea Correlation
coeﬃcients (r2) LODb LOQc
Canrenone 0.1∼3.0 y = 0.4587 + 1.2879x 0.9910 0.1mg/L 0.5mg/L
11-α-hydroxy-canrenone 0.1∼3.0 y = 0.3681 + 1.2274x 0.9928 0.12mg/L 0.67mg/L
ay and x stand for logarithmic values of peak area and concentration (g/L), respectively.
bLimit of detection (S/N = 3).
cLimit of quantiﬁcation (S/N = 10).
demonstrated that the transformation reaction through mi-
croorganism was successfully completed.
4.3. Validation of the Proposed Method
4.3.1. Linearity, LOD, and LOQ. According to the data in
Table 1, acceptable results of the regression analysis, the
correlation coeﬃcients (r2) ,L O D s ,a n dL O Q sw e r eo b t a i n e d
for all the analytes: both of the calibration curves showed
good linear regression (r2 ≥ 0.9911) within the test range;
the LODs and LOQs of the two sterols were in the range of
0.1∼0.12mg/L and 0.5∼0.67mg/L, respectively.
Accuracy, Repeatability, Precision, and Intermediate Precision.
Table 2 presents that the developed method had good
accuracy with the overall recovery of 91.75∼97.94%, with
the RSD 1.21%. The results of the repeatability test shown
in Table 3 demonstrated that the developed assay was re-
producible (RSD = 1.21%), and the intermediate precision
of this method was also acceptable (RSD = 1.37% and
1.21%). The stability test was chosen to determine the
precision of the HPLC-UV method. For the stability test
(Table 4), the analysis was performed by injecting the same
sample solution prepared in Section 3.2 in 6 diﬀerent hours:
0h, 4h, 8h, 12h, 18h, and 24h throughout a day , and
it was found to be rather stable daylong (RSD = 1.03%
and 1.35%). These results indicated that the HPLC-UVD
method is accurate, precise, and sensitive for quantitative
determination of canrenone and 11-α-hydroxy-canrenone in
the microbial transformation ﬂuid.
4.4. Application. The method was used to determine bio-
transformation broth of canrenone and 11α-hydroxy-can-
renone obtained after transformation simultaneously. Fig-
ure 4 showed the representative chromatograms of substrate
canrenone before transformation (Figure 4α), and of bio-
conversion broth obtained after conversion for 48h (Figure
4β) ,a n do fb l a n k( Figure 4γ). Comparing with the re-
presentative chromatograms of standard solution by LC-
MS/HPLC-UVD shown in Figures 2 and 3(C), it could be
seenthatcanrenoneand11α-hydroxy-canrenonewereeluted
at 29.05min and 33.33min without carryover, and 11-α-
hydroxy-canrenone existed as product in biotransformation
system. No other impurity peaks were found in Figure 3(C)6 Journal of Biomedicine and Biotechnology
Table 2: Accuracy of HPLC-UV method for canrenone.
Samples Original (g) Added (g) Found (g) Recoverya (%) Mean Recovery (%) RSDb (%)
1 0.0014 0.0097 0.0107 95.88
2 0.0015 0.0097 0.0104 91.75
3 0.0014 0.0097 0.0106 94.85 94.93 1.21
4 0.0013 0.0097 0.0108 97.94
5 0.0014 0.0097 0.0105 93.81
aRecovery (%) = ((canrenone amount found−original canrenone amount in sample solution)/canrenone added amount) × 100%.
b(RSD%) = (S.D./mean) × 100%.
Table 3: Repeatabilities and intermediate precisions of HPLC-UV method for canrenone and 11-α-hydroxy-canrenone.
Repeatabilitye (n = 5) Intermediate precisionf (n = 5)
Samples Content (g/L) RSD% Content (g/L) RSD%
abababab
1 1.3813 1.8343 2.2379 2.2127
2 1.3726 1.8387 2.2267 2.1567
3 1.3792 1.8814 0.99 1.03 2.2140 2.1479 1.37 1.21
4 1.4029 1.8471 2.2725 2.1704
5 1.4011 1.8609 2.2086 2.1914
aCanrenone.
b11-α-hydroxy-canrenone.
eFive samples was analyzed, and contents of each solution were used to access repeatability.
fThe mixed standard solutions with the same concentration were analyzed, and their contents were used to access intermediate precision.
Table 4: Precisions of HPLC-UV method for canrenone and 11-α-Hydroxy-canrenone.
Time (h)
Content (g/L) Mean content (g/L) RSD%
ababab
0
4
8
12
18
24
1.3813
1.3842
1.3930
1.3516
1.3760
1.3844
1.8343
1.9036
1.8679
1.8650
1.8834
1.8444
1.3784 1.8664 1.03 1.35
aCanrenone.
b11-α-hydroxy-canrenone.
and Figure 3(D). The obtained results indicated that the de-
tecting results were satisfactory, and the proposed method
could be applied to the following researches of biotransfor-
mation of canrenone to 11-α-hydroxy-canrenone in our lab-
oratory.
5. Conclusions
In this study, an HPLC coupled with MS and UVD method
hasbeenproposedforsimultaneousidentiﬁcationandquan-
tiﬁcation of canrenone and 11-α-hydroxy-canrenone in the
microbial transformation broth. The parameters evaluated
here demonstrated that the methods oﬀer good speciﬁcity,
linearity, accuracy, and precision within acceptable limits
while the LODs and LOQs conﬁrmed the eﬃciency of the
methodologies in quantifying low concentrations of sterols.
These results are deﬁnitely helpful to control the quality
of canrenone and 11-α-hydroxy-canrenone, and provide a
scientiﬁc basis for the search for the improvement the quality
of sterols products and transformation eﬃciency in the pro-
duction.
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